These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population. Butt AA; Yan P; Shaikh OS; Mayr FB; Omer SB Clin Infect Dis; 2022 Aug; 75(1):e849-e856. PubMed ID: 34893812 [TBL] [Abstract][Full Text] [Related]
3. Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population. Butt AA; Yan P; Shaikh OS; Mayr FB EClinicalMedicine; 2021 Oct; 40():101117. PubMed ID: 34476395 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers. Alishaq M; Nafady-Hego H; Jeremijenko A; Al Ajmi JA; Elgendy M; Vinoy S; Fareh SB; Veronica Plaatjies J; Nooh M; Alanzi N; Kaleeckal AH; Latif AN; Coyle P; Elgendy H; Abou-Samra AB; Butt AA PLoS One; 2021; 16(10):e0258820. PubMed ID: 34653228 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021. Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525 [TBL] [Abstract][Full Text] [Related]
6. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US. Sun J; Zheng Q; Madhira V; Olex AL; Anzalone AJ; Vinson A; Singh JA; French E; Abraham AG; Mathew J; Safdar N; Agarwal G; Fitzgerald KC; Singh N; Topaloglu U; Chute CG; Mannon RB; Kirk GD; Patel RC; JAMA Intern Med; 2022 Feb; 182(2):153-162. PubMed ID: 34962505 [TBL] [Abstract][Full Text] [Related]
7. Risk of breakthrough SARS-CoV-2 infection and clinical outcomes among vaccinated patients with type 2 diabetes. Bea S; Choi A; Kim JH; Cho YM; Choi WS; Jung J; Shin JY Diabetes Obes Metab; 2023 Sep; 25(9):2734-2742. PubMed ID: 37312652 [TBL] [Abstract][Full Text] [Related]
8. Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021. Wang W; Kaelber DC; Xu R; Berger NA JAMA Oncol; 2022 Jul; 8(7):1027-1034. PubMed ID: 35394485 [TBL] [Abstract][Full Text] [Related]
9. Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar. Butt AA; Dargham SR; Chemaitelly H; Al Khal A; Tang P; Hasan MR; Coyle PV; Thomas AG; Borham AM; Concepcion EG; Kaleeckal AH; Latif AN; Bertollini R; Abou-Samra AB; Abu-Raddad LJ JAMA Intern Med; 2022 Feb; 182(2):197-205. PubMed ID: 34935861 [TBL] [Abstract][Full Text] [Related]
10. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals. Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859 [TBL] [Abstract][Full Text] [Related]
11. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Taquet M; Dercon Q; Harrison PJ Brain Behav Immun; 2022 Jul; 103():154-162. PubMed ID: 35447302 [TBL] [Abstract][Full Text] [Related]
12. Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021. Teran RA; Walblay KA; Shane EL; Xydis S; Gretsch S; Gagner A; Samala U; Choi H; Zelinski C; Black SR MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):632-638. PubMed ID: 33914721 [TBL] [Abstract][Full Text] [Related]
14. Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer. Gong IY; Vijenthira A; Powis M; Calzavara A; Patrikar A; Sutradhar R; Hicks LK; Wilton D; Singh S; Krzyzanowska MK; Cheung MC JAMA Oncol; 2023 Mar; 9(3):386-394. PubMed ID: 36580318 [TBL] [Abstract][Full Text] [Related]
15. Breakthrough SARS-CoV-2 infection outcomes in vaccinated patients with chronic liver disease and cirrhosis: A National COVID Cohort Collaborative study. Ge J; Digitale JC; Pletcher MJ; Lai JC; Hepatology; 2023 Mar; 77(3):834-850. PubMed ID: 36799617 [TBL] [Abstract][Full Text] [Related]
16. Results of the Cologne Corona Surveillance (CoCoS) project- a cross-sectional study: survey data on risk factors of SARS-CoV-2 infection, and moderate-to-severe course in primarily immunized adults. Oberste M; Asenova T; Ernst A; Shah-Hosseini K; Schnörch N; Buess M; Rosenberger KD; Kossow A; Dewald F; Neuhann F; Hellmich M BMC Public Health; 2024 Feb; 24(1):548. PubMed ID: 38383381 [TBL] [Abstract][Full Text] [Related]
18. Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged ≥12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021. Naleway AL; Groom HC; Crawford PM; Salas SB; Henninger ML; Donald JL; Smith N; Thompson MG; Blanton LH; Bozio CH; Azziz-Baumgartner E MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(46):1608-1612. PubMed ID: 34793417 [TBL] [Abstract][Full Text] [Related]